As organizations invest in Artificial Intelligence (AI) and Machine Learning (ML), they inevitably run into a paradox. The automation that ML models offer can be a critical advantage for many ...

SAN DIEGO — An analysis comparing patient-level data from two recent phase 3 trials demonstrated an approximately 40% reduction in the risk for non–small cell lung cancer (NSCLC) recurrence or death ...